Exosome Diagnostics To Present At Fourth Annual OktoberINVESTfest, Bavaria Germany Investors Conference In New York
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced that Tom McLain, Chief Executive Officer of Exosome Diagnostics, will present today at the fourth annual OktoberINVESTfest at the New York Academy of Sciences in New York City.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.